Hla461 发表于 2025-3-25 06:45:10

http://reply.papertrans.cn/32/3170/316907/316907_21.png

净礼 发表于 2025-3-25 11:27:15

http://reply.papertrans.cn/32/3170/316907/316907_22.png

阶层 发表于 2025-3-25 15:16:54

http://reply.papertrans.cn/32/3170/316907/316907_23.png

avulsion 发表于 2025-3-25 16:13:25

http://reply.papertrans.cn/32/3170/316907/316907_24.png

harbinger 发表于 2025-3-25 22:34:12

Geopolitics of the Serial Killer,horization for accessing the European market, through multiple regulatory pathways operating at the European and national levels. The institutional structure governing marketing authorization includes the European Commission, the EMA and the NCAs of the member states. Thus relationships between the

遗传学 发表于 2025-3-26 01:32:35

http://reply.papertrans.cn/32/3170/316907/316907_26.png

musicologist 发表于 2025-3-26 06:04:40

http://reply.papertrans.cn/32/3170/316907/316907_27.png

我说不重要 发表于 2025-3-26 12:23:49

http://reply.papertrans.cn/32/3170/316907/316907_28.png

Modicum 发表于 2025-3-26 14:22:21

Case Study on Pharmaceutical Regulation in Europe,ing the development trajectory. The formal review of the regulatory space in terms of rule making, rule application and rule adjudication in order to determine the multilevelness of the space, is discussed. Key responses of regulatees that reveal their perceptions and expectations with regard to leg

不如屎壳郎 发表于 2025-3-26 17:52:59

Case Study on Borderline Medical Products in Europe,therefore bound to escape determinative categories propounded within European regulations. The solution lies in appreciating the role played by deliberative institutional networks that are active contributors of regulatory disciplines and ensuring mechanisms by which judges will be able to access sc
页: 1 2 [3] 4 5
查看完整版本: Titlebook: European Regulation of Medical Devices and Pharmaceuticals; Regulatee Expectatio Nupur Chowdhury Book 2014 Springer International Publishin